A Phase 2/3, Multi-Center, Open-Label, Randomized Study Of Weekly Nab?- Paclitaxel In Combination With Gemcitabine Or Carboplatin, Compared To Gemcita
Posted Date: May 15, 2019
- Investigator: Mahmoud Charif
- Type of Study: Drug
The purpose of this study is to see if nab-paclitaxel plus chemotherapy is more effective than one of the existing treatments for triple-negative metastatic breast cancer. The study has two different portions. The first portion will decide which chemotherapy will be used in combination with nab-pac
Criteria:
To Be Eligible For The Study You Must Have Been Diagnosed With Metastatic Breast Cancer
Keywords:
Abi-007-Mbc-001, Breast, Her2 Negative, Metastatic, Cancer
For More Information:
Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu